Piramal Enterprises Ltd Share Price
(PEL)
₹990.9
as on 04:01PM, 25 Mar 2025
PEL Performance
Day's Low
Day's High
₹985.5Day's Price Range₹1,023.4552 Week's Low
52 Week's High
₹736.652-Week Price Range₹1,275
| Returns % | |
| 1 Month Return | + 12.92 % |
| 3 Month Return | -6.88 % |
| 1 Year Return | + 19.18 % |
| Market Stats | |
| Previous Close | ₹1,022.85 |
| Open | ₹1,019.50 |
| Volume | 6.22L |
| Upper Circuit | ₹1,125.10 |
| Lower Circuit | ₹920.60 |
| Market Cap | ₹23,062.99Cr |
PEL Fundamentals
P/E Ratio
44.24
PEG Ratio
0.39
Market Cap
₹23,062.99 Cr
P/B Ratio
0.88
EPS
-74.94
Dividend Yield
1.18
Sector
Finance
ROE
3.5
Mutual Fund Holdings of PEL
PEL Analyst Rating
based on 7 analysts
14.29%
Buy
28.57%
Hold
57.14%
Sell
Based on 7 analysts offering long term price targets for PEL. An average target of ₹951.57
Source: S&P Global Market Intelligence
PEL Share analysis
PEL price forecast by 7 analysts
Downside of
High
₹1100
Target
₹951.57
Low
₹800
PEL target price ₹951.57, a slight downside of -6.97% compared to current price of ₹990.9. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
PEL revenue growth forecast
Expected growth rate Q1, FY2027:
Forecast
Actual
Including amortisation and stock based compensations
PEL EPS growth forecast
EPS estimate Q1, FY2027:
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Piramal Enterprises Ltd
Piramal Enterprises Plans Rs 300 Crore Fundraising - 24 Mar, 2025
Piramal Enterprises Ltd. is set to consider raising up to Rs 300 crore through non-convertible debentures in an upcoming meeting. This follows a previous approval to raise Rs 450 crore via public issuance of similar instruments.Piramal Enterprises Plans Sale of Insurance Holdings - 17 Mar, 2025
Piramal Enterprises Ltd, led by Ajay Piramal, intends to sell its stakes in Shriram Group's insurance ventures for ₹4,000-5,000 crore, holding 15% in Shriram General Insurance and 13.3% in Shriram Life Insurance. Investment bankers Avendus Capital and Arpwood Capital have been appointed to facilitate the sale.RBI's Risk Weight Cut Boosts NBFC Lending - 04 Mar, 2025
The Reserve Bank of India's recent decision to reduce risk weights on bank loans to NBFCs and MFIs is seen as a positive signal for lending, encouraging banks to support these institutions in contributing to economic growth.Piramal Enterprises Faces ₹1,502 Crore Tax Demand - 28 Feb, 2025
Piramal Enterprises has received a ₹1,502 crore GST demand related to its 2021 pharma business sale. The company disputes the demand and plans to challenge it, asserting it will not impact financial statements.
Insights on Piramal Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 14.93% to 16.43% in Dec 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 2.25K Cr → 2.88K Cr (in ₹), with an average increase of 11.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.5% return, outperforming this stock by 192.1%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 74.3% return, outperforming this stock by 55.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 46.30% of holdings in Dec 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 181.48 Cr → 38.56 Cr (in ₹), with an average decrease of 43.3% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 23.41% to 23.08% in Dec 2024 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 7.78% to 6.81% in Dec 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, PEL stock has moved down by -53.6%
PEL Financials
PEL Index Inclusions
PEL Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 46.3% | 0.00 | |
| Foreign Institutions | 16.43% | 10.04 | |
| Mutual Funds | 6.81% | ||
| Retail Investors | 23.08% | ||
| Others | 7.38% |
PEL Key Indicators
PEL Valuation
PEL in the last 5 years
Lowest (-15.04x)
December 11, 2024
Industry (26.18x)
March 24, 2025
Today (44.24x)
March 24, 2025
Highest (566.81x)
March 3, 2021
PEL Earnings and Dividends
Piramal Enterprises Ltd Earnings Results
Piramal Enterprises Ltd’s net profit jumped 101.62% since last year same period to ₹38.56Cr in the Q3 2024-2025. On a quarterly growth basis, Piramal Enterprises Ltd has generated -76.34% fall in its net profits since last 3-months.
Read More about Earnings ResultsPiramal Enterprises Ltd Dividends May,2024
In the quarter ending March 2024, Piramal Enterprises Ltd has declared dividend of ₹10 - translating a dividend yield of 1.01%.
Read More about Dividends
PEL Technicals Summary
Bearish
Neutral
Bullish
Piramal Enterprises Ltd is currently in a Bullish trading position according to technical analysis indicators.
PEL Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| ₹23,062.99 Cr | 10% | 0.63 | -₹1,684 Cr | ₹10,110 Cr | ||
| NA | ₹365.07 Cr | 229.22% | 0.50 | ₹8 Cr | ₹84 Cr | |
| NA | ₹2,820.50 Cr | 325673.19% | 0.50 | ₹175 Cr | ₹235 Cr | |
| NA | ₹5.52 Cr | 220.56% | 0.90 | NA | NA | |
| NA | ₹765.69 Cr | 125.25% | 0.50 | ₹324 Cr | ₹412 Cr |
About PEL
Piramal Pharma is the flagship company of Piramal Enterprises Ltd. It is a global leader in contract manufacturing and custom research services, offering a range of products and services to global customers. In the pharmaceuticals sector, Piramal Pharma manufactures and markets a wide range of generic, prescription and over-the-counter (OTC) drugs, including antibiotics, anti-inflammatory, cardiovascular, CNS, dermatology, diabetes, gastrointestinal, anti-infective, pain management and respiratory products. Piramal Capital & Housing Finance is another key business of Piramal Enterprises Ltd. It provides customized financial solutions for individuals and businesses, including home loans, loan against property, loan against securities and non-banking financial services.
Revenue: ₹2,882.76Cr as on December 2024 (Q4 24)
Net Profit: ₹38.56Cr as on December 2024 (Q4 24)
Listing date: 03 Nov, 1994
Chairperson Name: Ajay G Piramal
| Organisation | PEL |
| Headquarters | |
| Industry | Finance |
| E-voting on shares | Click here to vote |
FAQs on Piramal Enterprises Ltd
What is Piramal Enterprises Ltd price today?
Piramal Enterprises Ltd share price today stands at ₹990.9, Open: ₹1019.5, Previous Close: ₹1022.85, High: ₹1023.45, Low: ₹985.5, 52 Week High: ₹1275, 52 Week Low: ₹736.6.
How to Buy Piramal Enterprises Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Piramal Enterprises Ltd shares
What are today's traded volumes of Piramal Enterprises Ltd?
Today's traded volume of Piramal Enterprises Ltd(PEL) is 6.22L.
What is today's market capitalisation of Piramal Enterprises Ltd?
Today's market capitalisation of Piramal Enterprises Ltd(PEL) is ₹23062.99Cr.
What is the 52 Week High and Low Range of Piramal Enterprises Ltd?
How much percentage Piramal Enterprises Ltd is down from its 52 Week High?
Piramal Enterprises Ltd (PEL) share price is ₹990.9. It is down -22.28% from its 52 Week High price of ₹1275
How much percentage Piramal Enterprises Ltd is up from its 52 Week low?
Piramal Enterprises Ltd (PEL) share price is ₹990.9. It is up 34.52% from its 52 Week Low price of ₹736.6